BAG-1M: A potential specificity determinant of corticosteroid receptor action

Kidney International

Volumn 57, Issue 4, 2000, Pages 1265-1269

  Crocoll, Alexander ^a   Schneikert, Jean ^a   Hübner, Susanne ^a   Martin, Elke ^a   Cato, Andrew C B ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

BAG 1M; Eukaryotic cochaperone; Glucocorticoid receptor; Kidney development; Mineralocorticoid receptor

Indexed keywords

CELL DNA; CHAPERONE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PROTEIN BAG 1M; UNCLASSIFIED DRUG;

CONFERENCE PAPER; HORMONE ACTION; HORMONE RECEPTOR TRANSLOCATION; KIDNEY DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSACTIVATION;

EID: 0034110785     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00960.x     Document Type: Conference Paper

References (35)

1. 1. PRATT WB, DITTMAK KD: Studies with purified chaperones advance the understanding of the mechanism of glucocorticoid receptor-hsp90 heterocomplex assembly. Trends Endocrinol Metab 5:244-252, 1998
2. 2. DITTMAR KD, PRATT WB: Folding of the glucocorticoid receptor by the reconstituted hsp90-based chaperone machinery. J Biol Chem 272:13047-13054, 1997
3. 3. HARTL FU: Molecular chaperones in cellular protein folding. Nature 381:571-580, 1996
4. 4. RASSOW J, VON AHSEN O, BÖMER U, PFANNER N: Molecular chaperones: Towards a characterization of the heat-shock protein 70 family. Trends Cell Biol 7:129-133, 1997
5. 5. GEBAUER M, ZEINER M, GEHRING U: Proteins interacting with the molecular chaperone hsp70/hsc70: Physical associations and effects on refolding activity. FEBS Lett 417:109-113, 1997
6. 6. GEBAUER M, ZEINER M, GEHRING U: Interference between proteins Hap46 and Hop/p60, which bind to different domains of the molecular chaperone hsp70/hsc70. Mol Cell Biol 18:6238-6244, 1998
7. 7. JOHNSON BD, SCHUMACHER RJ, ROSS ED, TOFT DO: Hop modulates hsp70/hsp90 interactions in protein folding. J Biol Chem 273:3679-3686, 1998
8. 8. HÖHFELD J, MINAMI Y, HARTL F-U: Hip, a novel cochaperone involved in the eukaryotic hsc70/hsp40 reaction cycle. Cell 83:589-598, 1995
9. 9. FRYDMAN J, HÖHFELD J: Chaperones get in touch: The hip-hop connection. Trends Biochem Sci 22:87-92, 1997
10. 10. TAKAYAMA S, BIMSTON DN, MATSUZAWA S-I, FREEMAN BC, AIMESEMPE C, XIE Z, MORIMOTO RI, REED JC: BAG-1 modulates the chaperone activity of hsp70/hsc70. EMBO J 16:4887-4896, 1997
11. 11. STUART JK, MYSZKA DG, JOSS L, MITCHELL RS, MCDONALD SM, XIE Z, TAKAYAMA S, REED JC, ELY KR: Characterization of interactions between the anti-apoptotic protein BAG-1 and hsp70 molecular chaperones. J Biol Chem 273:22506-22514, 1998
12. 12. HÖHFELD J, JENTSCH S: GrpE-like regulation of the Hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J 16:6209-6216, 1997
13. 13. KULLMANN MJ, SCHNEIKERT J, MOLL J, HECK S, ZEINER M, GEHRING U, CATO ACB: RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J Biol Chem 273:14620-14625, 1998
14. 14. SCHNEIKERT J, HÜBNER S, MARTIN E, CATO ACB: A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity. J Cell Biol 146:929-940, 1999
15. 15. EDWARDS CRW, STEWART PM, BURT D, BRETT L, MCINTYRE MA, SUTANTO WS, DEKLOET ER, MONDER C: Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2:986-989, 1988
16. 16. FUNDER JW, PEARCE PT, SMITH R, SMITH AI: Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585, 1988
17. 17. LIM-TIO SS, FULLER PJ: Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139:1653-1661, 1998
18. 18. PEARCE D, YAMAMOTO KR: Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165, 1993
19. 19. PACKHAM G, BRIMMELL M, CLEVELAND JL: Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J 328:807-813, 1997
20. 20. FROESCH BA, TAKAYAMA S, REED JC: BAG-1L protein enhances androgen receptor function. J Biol Chem 273:11660-11666, 1998
21. 21. TAKAYAMA S, SATO T, KRAJEWSKI S, KOCHEL K, IRIE S, MILLAN JA, REED JC: Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284, 1995
22. 22. BARDELLI A, LONGATI P, ALBERO D, GORUPPI S, SCHNEIDER C, PONZETTO C, COMOGLIO PM: HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J 15:6205-6212, 1996
23. 23. MATSUZAWA S-I, TAKAYAMA S, FROESCH BA, ZAPATA JM, REED JC: p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: Suppression by BAG-1. EMBO J 17:2736-2747, 1998
24. 24. NAISHIRO Y, ADACHI M, OKUDA H, YAWATA A, MITAKA T, TAKAYAMA S, REED JC, HINODA Y, IMAI K: BAG-1 accelerates cell motilily of human gastric cancer cells. Oncogene 18:3244-3251, 1999
25. 25. LUI R, TAKAYAMA S, ZHENG Y, FROESCH B, CHEN G-Q, XHANG X, REED JC, ZHANG X-K: Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells. J Biol Chem 273:16985-16992, 1998
26. 26. ARRIZA JL: Aldosterone action: Perspectives from the cloning of the mineralocorticoid receptor, in Aldosterone. Fundamental Aspects, edited by BONVALET JP, FARMAN N, LOMBÈS M, RAFESTIN-OBLIN M-E, Paris, John Libbey Eurotext Ltd., 1991, pp 13-21
27. 27. YANG X, CHERNENKO G, HAO Y, DING Z, PATER MM, PATER A, TANG S-C: Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene 17:981-989, 1998
28. 28. TAKAYAMA S, KRAJEWSKI S, KRAJEWSKA M, KITADA S, ZAPATA JM, KOCHEL K, KNEE D, SCUDIERO D, TUDOR G, MILLER GJ, MIYASHITA T, YAMADA M, REED JC: Expression and localization of Hsp70/ Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissue and tumor cell lines. Cancer Res 58:3116-3131, 1998
29. 29. CRABTREE GR, BLOOMFIELD CD, SMITH KA, MCKENNA BA, PETERSON BA, HILDEBRANDT L, MUNCK A: Glucocorticoid receptors and in vitro responses to glucocorticoid in acute nonlymphocytic leukemia. Cancer Res 41:4853-4856, 1981
30. 30. WELLS RJ, MASCARO K, YOUNG PC, PROVISOR AJ, CLEARY RE, BAEHNER RL: Normal glucocorticoid receptor numbers in a child with glucocorticoid-resistant relapsed acute lymphocytic leukemia. Am J Pediatr Hematol Oncol 3:3-7, 1981
31. 31. EDWARDS CRW, BENEDIKTSSON R, LINDSAY RS, SECKL JR: Dysfunction of placental glucocorticoid barrier: Link between fetal environment and adult hypertension? Lancet 341:355-357, 1993
32. 32. BROWN RW, DIAZ R, ROBSON AC, KOTELEVTSEV MULLINS JJ, KAUFMAN MH, SECKL JR: The ontogeny of 11β-steroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137:794-797, 1996
33. 33. BELO JA, BOUWMEESTER T, LEYNS L, KERTESZ NO, GALLO M, FOLLETTIE M, DE ROBERTIS EM: Cerberus-like is a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula. Mech Dev 68:45-57, 1997
34. 34. HOGAN BLM, BEDDINGTON R, COSTANTINI F, LACY E: Manipulating the Mouse Embryo: A Laboratory Manual (2nd ed). Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1994
35. 35. MOSER M, PSCHERER A, ROTH C, BECKER J, MÜCHER G, ZERRES K, DIXKENS C, WEIS J, GUAY-WOODFORD L, BUETTNER R, FÄSSLER R: Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev 11:1938-1948